"Patient enrolment in BNC210 exploratory clinical trial to treat Agitation in elderly patients in a hospital/nursing home setting is now complete and top line data are expected by the end of June 2019."
That's all I needed to hear.
- Forums
- ASX - By Stock
- BNO
- Ann: Strategic Review Outcome and Program Updates
Ann: Strategic Review Outcome and Program Updates, page-4
Featured News
Add BNO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online